A case report described an infant with concurrent HDFN and SMA who was succesfully treated with an onasemnogene abeparvovec ...
Sales growth driven by continued strong performance from Entresto (+31% cc), Cosentyx (+25% cc), Kesimpta (+49% cc), Kisqali (+49% cc), Pluvicto (+42% cc) and Leqvio (+114% cc) Core operating income ...
Background: Spinal and bulbar muscular atrophy (SBMA) or Kennedy disease [OMIM ... consent form and allowed anonymised publication of their clinical information and photos. The study included all ...
A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
News Medical on MSN1d
Neurostimulation improves movement in adults with spinal muscle atrophyA new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback